120 related articles for article (PubMed ID: 38621912)
21. ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma.
Wang X; Yao L; Li Z; Zhang J; Ruan M; Mulati Y; Gan Y; Zhang Q
Int J Biol Sci; 2024; 20(2):643-663. PubMed ID: 38169650
[No Abstract] [Full Text] [Related]
22. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
Qu M; Li J; Yuan L
Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
[TBL] [Abstract][Full Text] [Related]
23. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
24. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
25. Combining Network Pharmacology and Experimental Validation to Study the Action and Mechanism of Water extract of Asparagus Against Colorectal Cancer.
Liang H; Li Y; Wang F; Zhao J; Yang X; Wu D; Zhang C; Liu Y; Huang J; Su M; He Z; Liu Y; Wang J; Tang D
Front Pharmacol; 2022; 13():862966. PubMed ID: 35774597
[No Abstract] [Full Text] [Related]
26. [Molecular mechanism of ginsenoside Rg_1 against radiation enteritis: based on network pharmacology and in vitro experiment].
Wang YG; Dou YQ; Yan ZQ; Gao Y
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(10):2810-2819. PubMed ID: 37282941
[TBL] [Abstract][Full Text] [Related]
27. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
28. MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway.
Fu JH; Yang S; Nan CJ; Zhou CC; Lu DQ; Li S; Mu HQ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):351-357. PubMed ID: 29424922
[TBL] [Abstract][Full Text] [Related]
29. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
[TBL] [Abstract][Full Text] [Related]
30. MRPS9-Mediated Regulation of the PI3K/Akt/mTOR Pathway Inhibits Neuron Apoptosis and Protects Ischemic Stroke.
Jiang J; Qi T; Li L; Pan Y; Huang L; Zhu L; Zhang D; Ma X; Qin Y
J Mol Neurosci; 2024 Feb; 74(1):23. PubMed ID: 38381220
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
Li KW; Wang SH; Wei X; Hou YZ; Li ZH
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
[TBL] [Abstract][Full Text] [Related]
32. Study on the mechanism of Cortex Lycii on lung cancer based on network pharmacology combined with experimental validation.
Guo Z; Yin H; Wu T; Wu S; Liu L; Zhang L; He Y; Zhang R; Liu N
J Ethnopharmacol; 2022 Jul; 293():115280. PubMed ID: 35405252
[TBL] [Abstract][Full Text] [Related]
33. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
Liang W; Wang C; Wang J; Zhang M
Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
[TBL] [Abstract][Full Text] [Related]
34. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zhu J; Lv J; Chen J; Zhang X; Ji Y
Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
[No Abstract] [Full Text] [Related]
35. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
36. [Mechanism of bulleyaconitine A in inhibiting bone destruction of rheumatoid arthritis via Src/PI3K/Akt signaling pathway].
Huang FY; Guo WY; Chen PP; Zhang XZ; Li ZH; Huang HL; Lin N; Su XH; Kong XY
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1438-1445. PubMed ID: 38621927
[TBL] [Abstract][Full Text] [Related]
37. Exploring the mechanism of bioactive components of Prunella vulgaris L. in treating hepatocellular carcinoma based on network pharmacology.
Tu H; Feng Y; Wang W; Zhou H; Cai Q; Feng Y
Chem Biol Drug Des; 2024 Jan; 103(1):e14413. PubMed ID: 38040415
[TBL] [Abstract][Full Text] [Related]
38. UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway.
Lu ZN; Song J; Sun TH; Sun G
Chin Med J (Engl); 2021 Oct; 134(20):2465-2474. PubMed ID: 34620747
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
Li H; Jin X; Zhang Z; Xing Y; Kong X
Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
[TBL] [Abstract][Full Text] [Related]
40. Single-cell RNA sequencing reveals the mechanism of PI3K/AKT/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation.
Xu L; Ding R; Song S; Liu J; Li J; Ju X; Ju B
J Gene Med; 2024 Jan; 26(1):e3658. PubMed ID: 38282149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]